299 related articles for article (PubMed ID: 35549656)
1. Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing.
Johansen MD; Mahbub RM; Idrees S; Nguyen DH; Miemczyk S; Pathinayake P; Nichol K; Hansbro NG; Gearing LJ; Hertzog PJ; Gallego-Ortega D; Britton WJ; Saunders BM; Wark PA; Faiz A; Hansbro PM
Am J Respir Crit Care Med; 2022 Sep; 206(6):712-729. PubMed ID: 35549656
[No Abstract] [Full Text] [Related]
2. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD.
Baines KJ; Hsu AC; Tooze M; Gunawardhana LP; Gibson PG; Wark PA
Respir Res; 2013 Feb; 14(1):15. PubMed ID: 23384071
[TBL] [Abstract][Full Text] [Related]
3. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease.
Osan J; Talukdar SN; Feldmann F; DeMontigny BA; Jerome K; Bailey KL; Feldmann H; Mehedi M
Microbiol Spectr; 2022 Aug; 10(4):e0045922. PubMed ID: 35862971
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies.
Watson A; Spalluto CM; McCrae C; Cellura D; Burke H; Cunoosamy D; Freeman A; Hicks A; Hühn M; Ostridge K; Staples KJ; Vaarala O; Wilkinson T
Am J Respir Crit Care Med; 2020 Jan; 201(1):83-94. PubMed ID: 31461630
[No Abstract] [Full Text] [Related]
5. Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.
Hsu AC; Starkey MR; Hanish I; Parsons K; Haw TJ; Howland LJ; Barr I; Mahony JB; Foster PS; Knight DA; Wark PA; Hansbro PM
Am J Respir Crit Care Med; 2015 May; 191(9):1012-23. PubMed ID: 25751541
[TBL] [Abstract][Full Text] [Related]
6. Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon.
Kan-O K; Ramirez R; MacDonald MI; Rolph M; Rudd PA; Spann KM; Mahalingam S; Bardin PG; Thomas BJ
J Infect Dis; 2017 May; 215(10):1536-1545. PubMed ID: 28379462
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease.
Peng Y; Wang ZN; Chen SY; Xu AR; Fang ZF; Sun J; Zhou ZQ; Hou XT; Cen LJ; Ma JJ; Zhao JC; Guan WJ; Wang DY; Zhong NS
Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L712-L721. PubMed ID: 35318858
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia.
Chen R; Hui KP; Liang Y; Ng KC; Nicholls JM; Ip MS; Peiris M; Chan MC; Mak JC
Virol J; 2023 Apr; 20(1):65. PubMed ID: 37041586
[TBL] [Abstract][Full Text] [Related]
9. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
Rosendal E; Mihai IS; Becker M; Das D; Frängsmyr L; Persson BD; Rankin GD; Gröning R; Trygg J; Forsell M; Ankarklev J; Blomberg A; Henriksson J; Överby AK; Lenman A
mBio; 2022 Jun; 13(3):e0089222. PubMed ID: 35532162
[TBL] [Abstract][Full Text] [Related]
10. The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium.
Bonser LR; Eckalbar WL; Rodriguez L; Shen J; Koh KD; Ghias K; Zlock LT; Christenson S; Woodruff PG; Finkbeiner WE; Erle DJ
Am J Respir Cell Mol Biol; 2022 Apr; 66(4):391-401. PubMed ID: 34982656
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
12. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
14. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
15. Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD.
Osan JK; Talukdar SN; Feldmann F; DeMontigny BA; Jerome K; Bailey KL; Feldmann H; Mehedi M
bioRxiv; 2020 Nov; ():. PubMed ID: 33200131
[TBL] [Abstract][Full Text] [Related]
16. Impaired Antiviral Stress Granule and IFN-β Enhanceosome Formation Enhances Susceptibility to Influenza Infection in Chronic Obstructive Pulmonary Disease Epithelium.
Hsu AC; Parsons K; Moheimani F; Knight DA; Hansbro PM; Fujita T; Wark PA
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):117-27. PubMed ID: 26807508
[TBL] [Abstract][Full Text] [Related]
17. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
18. Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection.
Easley KF; Edenfield RC; Lott MEJ; Reed RC; Das Sarma J; Mehta AJ; Staitieh BS; Lipp EK; Cho IK; Johnson SK; Jones CA; Bebin-Blackwell AG; Levy JM; Tompkins SM; Easley CA; Koval M
Am J Physiol Lung Cell Mol Physiol; 2023 Nov; 325(5):L647-L661. PubMed ID: 37786945
[TBL] [Abstract][Full Text] [Related]
19. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
Kang K; Kim HH; Choi Y
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
